These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38206908)

  • 1. Protocol of efficacy of bifidobacteria intake on gastrointestinal symptoms in symptomatic type 2 diabetes mellitus patients in abdominis: An open-label, randomized controlled trial (Binary STAR study).
    Hashimoto Y; Kobayashi G; Kitagawa N; Okada H; Hamaguchi M; Fukui M
    PLoS One; 2024; 19(1):e0295998. PubMed ID: 38206908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial.
    Hata S; Nakajima H; Hashimoto Y; Miyoshi T; Hosomi Y; Okamura T; Majima S; Nakanishi N; Senmaru T; Osaka T; Okada H; Ushigome E; Hamaguchi M; Asano M; Yamazaki M; Fukui M
    J Diabetes Investig; 2022 Mar; 13(3):489-500. PubMed ID: 34665938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of probiotics,
    Hashimoto Y; Nakajima H; Hata S; Miyoshi T; Hosomi Y; Majima S; Nakanishi N; Senmaru T; Osaka T; Okada H; Ushigome E; Hamaguchi M; Asano M; Yamazaki M; Fukui M
    J Clin Biochem Nutr; 2020 Nov; 67(3):223-227. PubMed ID: 33293761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of
    Fuyuki A; Higurashi T; Kessoku T; Ashikari K; Yoshihara T; Misawa N; Iwaki M; Kobayashi T; Ohkubo H; Yoneda M; Usuda H; Wada K; Nakajima A
    Biosci Microbiota Food Health; 2021; 40(2):105-114. PubMed ID: 33996367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
    Makizaki Y; Uemoto T; Yokota H; Yamamoto M; Tanaka Y; Ohno H
    PLoS One; 2021; 16(3):e0248584. PubMed ID: 33750988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis.
    Makizaki Y; Maeda A; Oikawa Y; Tamura S; Tanaka Y; Nakajima S; Ohno H; Yamamura H
    Microbiol Immunol; 2019 Dec; 63(12):481-486. PubMed ID: 31544979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probiotics on digestibility and immunity in infants: A study protocol for a randomized controlled trial.
    Xiao L; Ding G; Ding Y; Deng C; Ze X; Chen L; Zhang Y; Song L; Yan H; Liu F; Ben X
    Medicine (Baltimore); 2017 Apr; 96(14):e5953. PubMed ID: 28383398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.
    Lai H; Li Y; He Y; Chen F; Mi B; Li J; Xie J; Ma G; Yang J; Xu K; Liao X; Yin Y; Liang J; Kong L; Wang X; Li Z; Shen Y; Dang S; Zhang L; Wu Q; Zeng L; Shi L; Zhang X; Tian T; Liu X
    Gut Microbes; 2023; 15(1):2197837. PubMed ID: 37078654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
    Kato S; Hamouda N; Kano Y; Oikawa Y; Tanaka Y; Matsumoto K; Amagase K; Shimakawa M
    Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1017-1025. PubMed ID: 28590519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
    Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
    Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors.
    Kawahara T; Makizaki Y; Oikawa Y; Tanaka Y; Maeda A; Shimakawa M; Komoto S; Moriguchi K; Ohno H; Taniguchi K
    PLoS One; 2017; 12(3):e0173979. PubMed ID: 28346473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial.
    Martoni CJ; Evans M; Chow CT; Chan LS; Leyer G
    J Dig Dis; 2019 Sep; 20(9):435-446. PubMed ID: 31271261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of probiotics on functional constipation in adults: A randomized, double-blind controlled trial.
    Mitelmão FCR; Häckel K; Bergamaschi CC; Gerenutti M; Silva MT; Balcão VM; Vila MMDC
    Medicine (Baltimore); 2022 Oct; 101(43):e31185. PubMed ID: 36316826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.
    Alyousif Z; Miller JL; Sandoval MY; MacPherson CW; Nagulesapillai V; Dahl WJ
    Trials; 2018 Apr; 19(1):256. PubMed ID: 29703235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study.
    Tabbers MM; de Milliano I; Roseboom MG; Benninga MA
    Nutr J; 2011 Feb; 10():19. PubMed ID: 21345213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.
    Alyousif Z; Miller JL; Auger J; Sandoval M; Piano A; Tompkins TA; Dahl WJ
    Mol Genet Genomic Med; 2020 Dec; 8(12):e1535. PubMed ID: 33103385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised, double-blind, placebo-controlled trial of
    Wang L; Wang L; Tian P; Wang B; Cui S; Zhao J; Zhang H; Qian L; Wang Q; Chen W; Wang G
    Food Funct; 2022 Feb; 13(3):1628-1640. PubMed ID: 35079761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviation of low-fiber diet-induced constipation by probiotic
    Makizaki Y; Maeda A; Oikawa Y; Tamura S; Tanaka Y; Nakajima S; Yamamura H
    Biosci Microbiota Food Health; 2019; 38(2):49-53. PubMed ID: 31106107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifidobacterium bifidum YIT 10347 fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms in healthy adults: A double-blind, randomized, placebo-controlled study.
    Gomi A; Yamaji K; Watanabe O; Yoshioka M; Miyazaki K; Iwama Y; Urita Y
    J Dairy Sci; 2018 Jun; 101(6):4830-4841. PubMed ID: 29573807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An efficacy and safety study of bifidobacterium tetragenous viable bacteria tablets in the treatment of constipation in patients with type 2 diabetes mellitus].
    Yuan T; Zhao WG; Cao Y; Li Q; Yao MX; Hao XX; Yu H; Jiang CE; Wang HF; Wang SP; Wei XB; Qiu W
    Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):252-257. PubMed ID: 29614582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.